tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market

Oncolys BioPharma, Inc. (4588) Financial Statements

Compare
0 Followers

Oncolys BioPharma, Inc. Financial Overview

Oncolys BioPharma, Inc.'s market cap is currently ¥44.44B. The company's EPS TTM is ¥-11.78; its P/E ratio is -18.47; Oncolys BioPharma, Inc. is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 31.38M¥ 63.04M¥ 976.18M¥ 642.49M¥ 314.18M
Gross Profit¥ 31.38M¥ 30.61M¥ 338.49M¥ 198.80M¥ 236.11M
Operating Income¥ -1.68B¥ -1.93B¥ -1.20B¥ -1.45B¥ -1.67B
EBITDA¥ -1.68B¥ -1.93B¥ -1.14B¥ -1.60B¥ -2.08B
Net Income¥ -1.68B¥ -1.94B¥ -1.15B¥ -1.62B¥ -2.10B
Balance Sheet
Cash & Short-Term Investments¥ 2.41B¥ 1.53B¥ 1.71B¥ 3.45B¥ 2.07B
Total Assets¥ 3.20B¥ 2.04B¥ 2.65B¥ 4.29B¥ 2.80B
Total Debt¥ 324.64M¥ 315.17M¥ 393.66M¥ 503.47M¥ 525.08M
Net Debt¥ -1.84B¥ -972.59M¥ -1.07B¥ -2.71B¥ -1.30B
Total Liabilities¥ 446.65M¥ 566.50M¥ 491.69M¥ 697.88M¥ 793.09M
Stockholders' Equity¥ 2.75B¥ 1.47B¥ 2.16B¥ 3.59B¥ 2.00B
Cash Flow
Free Cash Flow¥ -2.02B¥ -1.34B¥ -1.72B¥ -1.74B¥ -1.47B
Operating Cash Flow¥ -2.02B¥ -1.34B¥ -1.72B¥ -1.74B¥ -1.47B
Investing Cash Flow¥ -4.71M¥ -5.39M¥ 20.12M¥ -942.00K¥ -37.58M
Financing Cash Flow¥ 2.88B¥ 1.14B¥ -113.83M¥ 3.09B¥ 242.26M
Currency in JPY

Oncolys BioPharma, Inc. Earnings and Revenue History

Oncolys BioPharma, Inc. Debt to Assets

Oncolys BioPharma, Inc. Cash Flow

Oncolys BioPharma, Inc. Forecast EPS vs Actual EPS